|
GO accession | Biological process | NES | value |
|
GO:0009165 | Nucleotide biosynthetic process | −1.36 | 1.85E − 02 |
GO:0006338 | Chromatin remodeling | −1.76 | 1.85E − 02 |
GO:0046328 | Regulation of JNK cascade | 1.21 | 1.96E − 02 |
GO:0030968 | Endoplasmic reticulum unfolded protein response | 1.71 | 2.04E − 02 |
GO:0032069 | Regulation of nuclease activity | 1.65 | 2.04E − 02 |
GO:0016558 | Protein import into peroxisome matrix | 1.41 | 2.13E − 02 |
GO:0030259 | Lipid glycosylation | 1.56 | 2.22E − 02 |
GO:0090501 | RNA phosphodiester bond hydrolysis | −1.64 | 2.22E − 02 |
GO:0071695 | Anatomical structure maturation | 1.39 | 2.27E − 02 |
GO:0032869 | Cellular response to insulin stimulus | 1.35 | 2.27E − 02 |
GO:0016049 | Cell growth | 1.55 | 2.38E − 02 |
GO:0019321 | Pentose metabolic process | 1.44 | 2.44E − 02 |
GO:2001241 | Positive regulation of the extrinsic apoptotic signalling pathway in absence of ligand | 1.29 | 2.44E − 02 |
GO:2001239 | Regulation of the extrinsic apoptotic signalling pathway in the absence of ligand | 1.24 | 2.44E − 02 |
GO:0032092 | Positive regulation of protein binding | 1.64 | 2.50E − 02 |
GO:0045599 | Negative regulation of fat cell differentiation | 1.29 | 2.56E − 02 |
GO:0071479 | Cellular response to ionizing radiation | −1.37 | 3.17E − 02 |
GO:0006308 | DNA catabolic process | −1.56 | 3.28E − 02 |
GO:0000082 | G1/S transition of mitotic cell cycle | −1.77 | 3.28E − 02 |
GO:0044843 | Cell cycle G1/S phase transition | −1.77 | 3.28E − 02 |
GO:0090025 | Regulation of monocyte chemotaxis | 1.52 | 3.57E − 02 |
GO:0046325 | Negative regulation of glucose import | 1.34 | 3.57E − 02 |
GO:0010800 | Positive regulation of peptidyl-threonine phosphorylation | −1.28 | 3.57E − 02 |
GO:0007127 | Meiosis I | −1.66 | 3.64E − 02 |
GO:0002689 | Negative regulation of leukocyte chemotaxis | 1.81 | 3.70E − 02 |
GO:0006534 | Cysteine metabolic process | 1.32 | 3.70E − 02 |
GO:0090231 | Regulation of spindle checkpoint | −1.61 | 3.70E − 02 |
GO:1902850 | Microtubule cytoskeleton organization involved in mitosis | −1.73 | 3.70E − 02 |
GO:0032200 | Telomere organization | −1.88 | 3.70E − 02 |
GO:0071300 | Cellular response to retinoic acid | 1.26 | 3.77E − 02 |
GO:0006302 | Double-strand break repair | −1.88 | 3.77E − 02 |
GO:0031064 | Negative regulation of histone deacetylation | 1.47 | 3.85E − 02 |
GO:0010155 | Regulation of proton transport | 1.37 | 3.85E − 02 |
GO:0032924 | Activin receptor signalling pathway | −1.35 | 3.85E − 02 |
GO:0051181 | Cofactor transport | 1.62 | 3.92E − 02 |
GO:0000060 | Protein import into nucleus, translocation | −1.71 | 3.92E − 02 |
GO:1902668 | Negative regulation of axon guidance | 1.67 | 4.00E − 02 |
GO:0043388 | Positive regulation of DNA binding | 1.39 | 4.00E − 02 |
GO:0043320 | Natural killer cell degranulation | −1.34 | 4.00E − 02 |
GO:0010887 | Negative regulation of cholesterol storage | 1.62 | 4.08E − 02 |
GO:0032845 | Negative regulation of homeostatic process | 1.47 | 4.08E − 02 |
GO:0051896 | Regulation of protein kinase B signalling | 1.33 | 4.08E − 02 |
GO:0008334 | Histone mRNA metabolic process | −1.69 | 4.08E − 02 |
GO:0097191 | Extrinsic apoptotic signalling pathway | 1.22 | 4.17E − 02 |
GO:0002686 | Negative regulation of leukocyte migration | 1.53 | 4.26E − 02 |
GO:0048706 | Embryonic skeletal system development | 1.36 | 4.26E − 02 |
GO:0097035 | Regulation of membrane lipid distribution | 1.35 | 4.26E − 02 |
GO:0061157 | mRNA destabilization | −1.72 | 4.26E − 02 |
GO:2000615 | Regulation of histone H3-K9 acetylation | −1.73 | 4.26E − 02 |
GO:0072528 | Pyrimidine-containing compound biosynthetic process | −1.88 | 4.26E − 02 |
GO:1903036 | Positive regulation of response to wounding | 1.35 | 4.35E − 02 |
GO:1900746 | Regulation of vascular endothelial growth factor signalling pathway | −1.53 | 4.35E − 02 |
GO:0009303 | rRNA transcription | −1.45 | 4.41E − 02 |
GO:0045080 | Positive regulation of chemokine biosynthetic process | 1.88 | 4.44E − 02 |
GO:0008207 | C21-steroid hormone metabolic process | 1.69 | 4.44E − 02 |
GO:0050795 | Regulation of behavior | 1.51 | 4.44E − 02 |
GO:1902107 | Positive regulation of leukocyte differentiation | 1.28 | 4.44E − 02 |
GO:0017157 | Regulation of exocytosis | 1.16 | 4.44E − 02 |
GO:0007098 | Centrosome cycle | −1.42 | 4.44E − 02 |
GO:0001946 | Lymphangiogenesis | −1.43 | 4.48E − 02 |
GO:0050919 | Negative chemotaxis | 1.68 | 4.55E − 02 |
GO:0060338 | Regulation of the type I interferon-mediated signalling pathway | 1.65 | 4.55E − 02 |
GO:0050748 | Negative regulation of the lipoprotein metabolic process | 1.56 | 4.55E − 02 |
GO:0038031 | Noncanonical Wnt signalling pathway via JNK cascade | 1.53 | 4.55E − 02 |
GO:0010935 | Regulation of macrophage cytokine production | 1.49 | 4.55E − 02 |
GO:0060907 | Positive regulation of macrophage cytokine production | 1.40 | 4.55E − 02 |
GO:0034661 | ncRNA catabolic process | −1.71 | 4.55E − 02 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | −1.59 | 4.62E − 02 |
GO:1902624 | Positive regulation of neutrophil migration | 1.69 | 4.65E − 02 |
GO:2000406 | Positive regulation of T cell migration | 1.63 | 4.65E − 02 |
GO:2000403 | Positive regulation of lymphocyte migration | 1.56 | 4.65E − 02 |
GO:1901725 | Regulation of histone deacetylase activity | 2.14 | 4.76E − 02 |
GO:1902667 | Regulation of axon guidance | 1.81 | 4.76E − 02 |
GO:0048841 | Regulation of axon extension involved in axon guidance | 1.73 | 4.76E − 02 |
GO:0050882 | Voluntary musculoskeletal movement | 1.51 | 4.76E − 02 |
GO:0042113 | B cell activation | −1.19 | 4.76E − 02 |
GO:0072522 | Purine-containing compound biosynthetic process | −1.29 | 4.76E − 02 |
GO:1901991 | Negative regulation of mitotic cell cycle phase transition | −1.47 | 4.76E − 02 |
GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | −1.23 | 4.84E − 02 |
GO:2000757 | Negative regulation of peptidyl-lysine acetylation | −1.80 | 4.84E − 02 |
GO:0035067 | Negative regulation of histone acetylation | −1.83 | 4.84E − 02 |
GO:0007628 | Adult walking behavior | 1.94 | 4.88E − 02 |
GO:0021756 | Striatum development | −1.31 | 4.92E − 02 |
GO:1901988 | Negative regulation of cell cycle phase transition | −1.46 | 4.92E − 02 |
GO:0045185 | Maintenance of protein location | −1.48 | 4.92E − 02 |
GO:0051053 | Negative regulation of DNA metabolic process | −1.52 | 4.92E − 02 |
GO:0051258 | Protein polymerization | −1.53 | 4.92E − 02 |
GO:0044774 | Mitotic DNA integrity checkpoint | −1.68 | 4.92E − 02 |
GO:0009124 | Nucleoside monophosphate biosynthetic process | −1.71 | 4.92E − 02 |
GO:0043487 | Regulation of RNA stability | −1.75 | 4.92E − 02 |
GO:0034501 | Protein localization to kinetochore | −1.82 | 4.92E − 02 |
GO:0000077 | DNA damage checkpoint | −1.91 | 4.92E − 02 |
GO:0000079 | Regulation of cyclin-dependent protein serine/threonine kinase activity | −2.01 | 4.92E − 02 |
|